These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 28646475

  • 1. Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome.
    Sapuppo G, Palermo F, Russo M, Tavarelli M, Masucci R, Squatrito S, Vigneri R, Pellegriti G.
    J Endocrinol Invest; 2017 Dec; 40(12):1355-1363. PubMed ID: 28646475
    [Abstract] [Full Text] [Related]

  • 2. Lymph node location is a risk factor for papillary thyroid cancer-related death.
    Sapuppo G, Tavarelli M, Russo M, Malandrino P, Belfiore A, Vigneri R, Pellegriti G.
    J Endocrinol Invest; 2018 Nov; 41(11):1349-1353. PubMed ID: 29549629
    [Abstract] [Full Text] [Related]

  • 3. Prophylactic lymph node dissection in papillary thyroid carcinoma: is there a place for lateral neck dissection?
    Ducoudray R, Trésallet C, Godiris-Petit G, Tissier F, Leenhardt L, Menegaux F.
    World J Surg; 2013 Jul; 37(7):1584-91. PubMed ID: 23564213
    [Abstract] [Full Text] [Related]

  • 4. The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma.
    Jeon MJ, Yoon JH, Han JM, Yim JH, Hong SJ, Song DE, Ryu JS, Kim TY, Shong YK, Kim WB.
    Eur J Endocrinol; 2013 Feb; 168(2):219-25. PubMed ID: 23161752
    [Abstract] [Full Text] [Related]

  • 5. Correlation between the number of lymph node metastases and lung metastasis in papillary thyroid cancer.
    Machens A, Dralle H.
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4375-82. PubMed ID: 23019347
    [Abstract] [Full Text] [Related]

  • 6. Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management.
    Chéreau N, Buffet C, Trésallet C, Tissier F, Leenhardt L, Menegaux F.
    Surgery; 2016 Mar; 159(3):755-62. PubMed ID: 26435440
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for recurrent disease in small papillary thyroid cancers - a Swedish register-based study.
    Bayadsi H, Nylén C, Sandström M, Angelsten J, Sund M, Hennings J.
    Langenbecks Arch Surg; 2023 Apr 26; 408(1):162. PubMed ID: 37099203
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH, Shen WT, Gosnell J, Duh QY.
    Head Neck; 2015 Sep 26; 37(9):1336-43. PubMed ID: 24821456
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lateral Neck Lymph Node Characteristics Prognostic of Outcome in Patients with Clinically Evident N1b Papillary Thyroid Cancer.
    Wang LY, Palmer FL, Nixon IJ, Tuttle RM, Shah JP, Patel SG, Shaha AR, Ganly I.
    Ann Surg Oncol; 2015 Oct 26; 22(11):3530-6. PubMed ID: 25665952
    [Abstract] [Full Text] [Related]

  • 12. Differentiating the location of cervical lymph node metastasis is very useful for estimating the risk of distant metastases in papillary thyroid carcinoma.
    Jeon MJ, Kim TY, Kim WG, Han JM, Jang EK, Choi YM, Song DE, Yoon JH, Chung KW, Hong SJ, Shong YK, Kim WB.
    Clin Endocrinol (Oxf); 2014 Oct 26; 81(4):593-9. PubMed ID: 24750108
    [Abstract] [Full Text] [Related]

  • 13. Long-term efficacy of lobectomy for stage T1 papillary thyroid carcinoma with varying degrees of lymph node metastasis.
    Qin C, Cai S, Qi Y, Liu M, Xu W, Yin M, Tang H, Ji Q, Liao T, Wang Y.
    Front Endocrinol (Lausanne); 2024 Oct 26; 15():1453601. PubMed ID: 39175578
    [Abstract] [Full Text] [Related]

  • 14. Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma.
    Ryu IS, Song CI, Choi SH, Roh JL, Nam SY, Kim SY.
    Ann Surg Oncol; 2014 Jan 26; 21(1):277-83. PubMed ID: 24006096
    [Abstract] [Full Text] [Related]

  • 15. Identifying risk factors for recurrence of papillary thyroid cancer in patients who underwent modified radical neck dissection.
    Ryu YJ, Cho JS, Yoon JH, Park MH.
    World J Surg Oncol; 2018 Oct 12; 16(1):205. PubMed ID: 30314503
    [Abstract] [Full Text] [Related]

  • 16. Level I lymph node involvement in patients with N1b papillary thyroid carcinoma: a prospective study.
    Eweida AM, Sakr MF, Hamza Y, Khalil MR, Gabr E, Koraitim T, Al-Wagih HF, Abo-Elwafa W, Ezzat Abdel-Aziz T, Diab AA, El-Sabaa B, Nabawi AS.
    Eur Arch Otorhinolaryngol; 2017 Apr 12; 274(4):1951-1958. PubMed ID: 27999997
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The Effectiveness of Prophylactic Modified Neck Dissection for Reducing the Development of Lymph Node Recurrence of Papillary Thyroid Carcinoma.
    Ito Y, Miyauchi A, Kudo T, Kihara M, Fukushima M, Miya A.
    World J Surg; 2017 Sep 12; 41(9):2283-2289. PubMed ID: 28429089
    [Abstract] [Full Text] [Related]

  • 19. Predictors of lateral lymph node metastasis and skip metastasis in patients with papillary thyroid microcarcinoma.
    Yoon JH, Park JY, Hong AR, Kim HK, Kang HC.
    Front Endocrinol (Lausanne); 2024 Sep 12; 15():1392247. PubMed ID: 39015180
    [Abstract] [Full Text] [Related]

  • 20. Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis.
    Back K, Kim TH, Lee J, Kim JS, Choe JH, Oh YL, Cho A, Kim JH.
    J Pediatr Surg; 2023 Mar 12; 58(3):568-573. PubMed ID: 35973863
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.